SCHEMBL19934782

SCHEMBL19934782

COC(=O)c1cc(OC)cc2oc(-c3ccc(OC)cc3)c(-c3cc(OC)cc(OC)c3)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ HPGD P15428 4/20 0.51
▸ MAPT P10636 3/20 0.51
▸ ABCG2 Q9UNQ0 1/20 0.49
▸ CYP1A2 P05177 3/20 0.49
▸ CYP2D6 P10635 2/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ ATM Q13315 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ SLC22A2 O15244 1/20 0.47
▸ SLC22A1 O15245 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47
▸ MAOA P21397 2/20 0.44
▸ ABCB1 P08183 2/20 0.44
▸ CYP1A1 P04798 1/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ FTO Q9C0B1 1/20 0.44
▸ CYP3A4 P08684 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19934809 0.92 ADORA3 (0.48) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL19934810 0.91 KDM4E (0.48) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL28654875 0.89 KDM4E (0.50) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL30022955 0.89 KDM4E (0.50) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL30081078 0.88 ABCG2 (0.47) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL28873061 0.88 ABCG2 (0.47) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL30081072 0.87 MEN1 (0.47) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL28873059 0.87 MEN1 (0.47) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL30081092 0.86 KMT2A (0.47) ALDH1A1KDM4EHPGDMAPTABCG2
SCHEMBL28873052 0.86 KMT2A (0.47) ALDH1A1KDM4EHPGDMAPTABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-12-17 — — US disclosed
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HPGDS, DPP7, DPEP1 ALDH1A1 2161/4885KDM4E 3016/4885HPGD 61/4885
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them HPGDS, DPP7, DPEP1 ALDH1A1 2161/4885KDM4E 3016/4885HPGD 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback